Postmarket Clinical Follow-Up Study on Arcadius XP L® Interbody Fusion Device

Multicenter, Not Randomised, Non-interventional, Postmarket Clinical Follow-Up (PMCF) Study on the Performance / Safety of Arcadius XP L® Interbody Fusion Device

The purpose of this study is to collect clinical and radiological mid-term (min. 1 year) data on the ArcadiusXP L® lumbar stand-alone cage in a post-market clinical follow-up study (PMCF) limited to 60 patients.

Inclusion Criteria:

• all patients who received a Arcadius XP L® interbody fusion device between 2016 until approx. January 2021 (minimum Follow-up is one year) in the study center
• all indications as given by the instructions for use: degenerative disc disease (DDD), Instability, Spondylolisthesis up to grade 1, Post-discectomy syndrome, Post-traumatic instability
• Written informed consent for the documentation of clinical and radiological results

Exclusion Criteria:

• Patient is not willing or able to participate at the follow-up examination
• Patients living outside a radius of 100 km around the study center
• all contraindications as given by the instructions for use: